Undifferentiated Pleomorphic Sarcoma

Also known as: Fibrous histiocytoma, malignant (morphologic abnormality) / Fibrous histiocytoma malignant / Malignant fibrous histiocytoma / Malignant fibrous histiocytoma (disorder) / Malignant fibrous histiocytoma NOS / Fibrous histiocytomas malignant / Histiocytoma, Malignant Fibrous / [M]Fibroxanthosarcoma (morphologic abnormality) / [M]Fibroxanthosarcoma / Malignant fibrous histiocytoma stage unspecified

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB11945Avelumab1Active Not Recruiting1
DB06186Ipilimumab1Active Not Recruiting1
DB09035Nivolumab1Active Not Recruiting1
DB09073Palbociclib1Recruiting1
DB09037Pembrolizumab1Recruiting1
DB09037Pembrolizumab1Terminated1
DB17520Vimseltinib1Active Not Recruiting1
DB11885Anlotinib2Not Yet Recruiting1
DB08875Cabozantinib2Recruiting1
DB00970Dactinomycin2Recruiting1
DB00380Dexrazoxane2Completed1
DB01248Docetaxel2Withdrawn2
DB00997Doxorubicin2Completed1
DB00997Doxorubicin2Not Yet Recruiting1
DB16047Elraglusib2Withdrawn2
DB15769Envafolimab2Recruiting1
DB08871Eribulin2Active Not Recruiting1
DB00441Gemcitabine2Withdrawn2
DB01181Ifosfamide2Not Yet Recruiting1
DB06186Ipilimumab2Active Not Recruiting1
DB06186Ipilimumab2Recruiting1
DB01042Melphalan2Recruiting1
DB09035Nivolumab2Active Not Recruiting1
DB09037Pembrolizumab2Active Not Recruiting1
DB09037Pembrolizumab2Recruiting3
DB00571Propranolol2Recruiting1
DB13896Talimogene laherparepvec2Active Not Recruiting1
DB15043Toripalimab2Not Yet Recruiting1
DB08896RegorafenibNot AvailableRecruiting1
DB05109TrabectedinNot AvailableRecruiting1